Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Ocular-selective oral VEGFR-2 inhibitors for wet AMD reported by Novartis

Aug. 20, 2015

Amgen provides early preclinical data on TRPM8 antagonist for migraine

Aug. 20, 2015

AbbVie presents selective P2X3 receptor antagonists for pain management

Aug. 20, 2015

New translocator protein ligands target mitochondrial dysfunction in Alzheimer's disease

Aug. 19, 2015

Novel SYK inhibitor shows antitumor activity in preclinical models

Aug. 19, 2015

Novartis gives details on early testing of potent BCR-ABL allosteric inhibitor

Aug. 19, 2015

Discovery and optimization of novel HIV integrase inhibitors from BMS

Aug. 19, 2015

Merck & Co. describes discovery of novel DGAT2 inhibitors

Aug. 19, 2015

Novel alpha7 nACh receptor partial agonist shows potential for use in schizophrenia

Aug. 18, 2015

AstraZeneca positions antitumor compound AZD-4320 for clinical development

Aug. 18, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...